162 related articles for article (PubMed ID: 26958868)
1. Post-Translational Regulation of the Glucose-6-Phosphatase Complex by Cyclic Adenosine Monophosphate Is a Crucial Determinant of Endogenous Glucose Production and Is Controlled by the Glucose-6-Phosphate Transporter.
Soty M; Chilloux J; Delalande F; Zitoun C; Bertile F; Mithieux G; Gautier-Stein A
J Proteome Res; 2016 Apr; 15(4):1342-9. PubMed ID: 26958868
[TBL] [Abstract][Full Text] [Related]
2. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
4. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis.
Konopelska S; Kienitz T; Quinkler M
Obesity (Silver Spring); 2011 Dec; 19(12):2322-6. PubMed ID: 21593806
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the expression of both the hydrolase and translocase components of hepatic glucose-6-phosphatase in murine pancreatic islets.
Goh BH; Efendić S; Khan A; Portwood N
Biochem Biophys Res Commun; 2003 Aug; 307(4):935-41. PubMed ID: 12878201
[TBL] [Abstract][Full Text] [Related]
7. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
[TBL] [Abstract][Full Text] [Related]
8. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
Pan CJ; Chen SY; Jun HS; Lin SR; Mansfield BC; Chou JY
PLoS One; 2011; 6(9):e23157. PubMed ID: 21949678
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
Chen LY; Pan CJ; Shieh JJ; Chou JY
Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
[TBL] [Abstract][Full Text] [Related]
10. The biochemistry and molecular biology of the glucose-6-phosphatase system.
Foster JD; Nordlie RC
Exp Biol Med (Maywood); 2002 Sep; 227(8):601-8. PubMed ID: 12192101
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Seo HY; Kim MK; Min AK; Kim HS; Ryu SY; Kim NK; Lee KM; Kim HJ; Choi HS; Lee KU; Park KG; Lee IK
Endocrinology; 2010 Feb; 151(2):561-8. PubMed ID: 20022930
[TBL] [Abstract][Full Text] [Related]
12. The SLC37 family of phosphate-linked sugar phosphate antiporters.
Chou JY; Sik Jun H; Mansfield BC
Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A phosphorylates hepatocyte nuclear factor-6 and stimulates glucose-6-phosphatase catalytic subunit gene transcription.
Streeper RS; Hornbuckle LA; Svitek CA; Goldman JK; Oeser JK; O'Brien RM
J Biol Chem; 2001 Jun; 276(22):19111-8. PubMed ID: 11279202
[TBL] [Abstract][Full Text] [Related]
14. Liver-directed gene therapy for murine glycogen storage disease type Ib.
Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
[TBL] [Abstract][Full Text] [Related]
15. The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through RORα and SRC-2 coactivator transcriptional activity.
Madsen A; Bjune JI; Bjørkhaug L; Mellgren G; Sagen JV
Mol Cell Endocrinol; 2016 Jan; 419():92-101. PubMed ID: 26455881
[TBL] [Abstract][Full Text] [Related]
16. A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Hiraiwa H; Pan CJ; Lin B; Akiyama TE; Gonzalez FJ; Chou JY
J Biol Chem; 2001 Mar; 276(11):7963-7. PubMed ID: 11121425
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Wang Y; Oeser JK; Yang C; Sarkar S; Hackl SI; Hasty AH; McGuinness OP; Paradee W; Hutton JC; Powell DR; O'Brien RM
J Biol Chem; 2006 Dec; 281(52):39982-9. PubMed ID: 17023421
[TBL] [Abstract][Full Text] [Related]
18. Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Foster JD; Wiedemann JM; Pan CJ; Chou JY; Nordlie RC
Arch Biochem Biophys; 2001 Sep; 393(1):117-22. PubMed ID: 11516168
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of type 1 glycogen storage diseases.
Chou JY
Curr Mol Med; 2001 Mar; 1(1):25-44. PubMed ID: 11899241
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology and gene therapy for glycogen storage disease type Ib.
Chou JY; Cho JH; Kim GY; Mansfield BC
J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
